mhurhangee/ep-ind-claims huggingface dataset:
A cover assembly for a mattress, comprising: a first cover having a top panel, a bottom panel, and a continuous side panel including a head panel, a foot panel and a two opposing side panels (136, 138) collectively defining a cavity for enclosing the mattress; a second cover having a top surface and a bottom surface, the second cover defining a perimeter, and the second cover positioned over and dimensionally-sized to cover at least the top panel of the first cover; and a fastener connecting the second cover to the first cover along the perimeter of the second cover, being characterized in that the second cover is dimensionally-sized to also cover an upper half (137, 139) of each opposing side panel (136, 137), an upper half of the foot panel, and an upper half of the head panel; and that the fastener is a two-way separating zipper having two slider bodies (152a, 152b) with zipper pulls (153a, 153b). a first cover having a top panel, a bottom panel, and a continuous side panel including a head panel, a foot panel and a two opposing side panels (136, 138) collectively defining a cavity for enclosing the mattress; a second cover having a top surface and a bottom surface, the second cover defining a perimeter, and the second cover positioned over and dimensionally-sized to cover at least the top panel of the first cover; and a fastener connecting the second cover to the first cover along the perimeter of the second cover, being characterized in that the second cover is dimensionally-sized to also cover an upper half (137, 139) of each opposing side panel (136, 137), an upper half of the foot panel, and an upper half of the head panel; and that the fastener is a two-way separating zipper having two slider bodies (152a, 152b) with zipper pulls (153a, 153b).
An implantable system for neuromodulation of cranial nerves, the system comprising: a first housing configured for implantation in an anterior cervical region of a patient, at or under a mandible of the patient; a first electrode lead coupled to the first housing, the first electrode lead comprising at least one electrode configured to be disposed at or near a first cranial nerve target in the patient, wherein the first cranial nerve target comprises a main body of a hypoglossal nerve of the patient or a branch of the hypoglossal nerve of the patient; and a signal generator circuit provided in the first housing and configured to generate electrical neuromodulation signals for delivery to the cranial nerve target using the at least one electrode of the first electrode lead, the system further comprising: a second electrode lead coupled to the first housing (1004; 1102), characterised in the second electrode lead comprising at least one electrode configured to be disposed at or near a second cranial nerve target in the patient, and wherein the signal generator circuit is configured to generate respective neuromodulation signals for delivery to the first and second cranial nerve targets using the electrodes on the first and second electrode leads (606, 712) to treat obstructive sleep apnea. a first housing configured for implantation in an anterior cervical region of a patient, at or under a mandible of the patient; a first electrode lead coupled to the first housing, the first electrode lead comprising at least one electrode configured to be disposed at or near a first cranial nerve target in the patient, wherein the first cranial nerve target comprises a main body of a hypoglossal nerve of the patient or a branch of the hypoglossal nerve of the patient; and a signal generator circuit provided in the first housing and configured to generate electrical neuromodulation signals for delivery to the cranial nerve target using the at least one electrode of the first electrode lead,
A method for purifying a biologic composition, comprising diafiltering the biologic composition with phosphate buffered saline to obtain a purified composition, wherein the biologic composition comprises a ch14.18 monoclonal antibody.
Triazine derivative chosen from (+)-2-amino-3,6-dihydro-4-dimethylamino-6-methyl-1,3,5-triazine or a pharmaceutically acceptable salt thereof, for use in a method for the treatment to delay the onset of type 2 diabetes by protecting beta cells from cellular death, wherein the subject to be treated has pre-diabetes.
A water-based ink comprising a pigment, a water-soluble organic solvent, a surfactant and water, in which: a content of water in the water-based ink is not less than 45% by mass and not more than 60% by mass, a boiling point of the water-soluble organic solvent is not higher than 230°C, and a content of a high-boiling point organic solvent having a boiling point of not lower than 250°C in the water-based ink is not more than 4% by mass; and the surfactant comprises a silicone-based surfactant (d-1) and an acetylene glycol-based surfactant (d-2) which satisfy the following conditions 1 and 2: [(content of component (d-1))/(content of component)] x 100 = 0.15 to 4; and [(content of component (d-2))/(content of component)] x 100 = 0.35 to 1.65; and wherein the water-soluble organic solvent means such an organic solvent whose solubility in water as measured by dissolving the organic solvent in 100 g of ion-exchanged water at 25°C until reaching a saturated concentration thereof is not less than 10 g. a content of water in the water-based ink is not less than 45% by mass and not more than 60% by mass, a boiling point of the water-soluble organic solvent is not higher than 230°C, and a content of a high-boiling point organic solvent having a boiling point of not lower than 250°C in the water-based ink is not more than 4% by mass; and the surfactant comprises a silicone-based surfactant (d-1) and an acetylene glycol-based surfactant (d-2) which satisfy the following conditions 1 and 2: [(content of component (d-1))/(content of component)] x 100 = 0.15 to 4; and [(content of component (d-2))/(content of component)] x 100 = 0.35 to 1.65; and wherein the water-soluble organic solvent means such an organic solvent whose solubility in water as measured by dissolving the organic solvent in 100 g of ion-exchanged water at 25°C until reaching a saturated concentration thereof is not less than 10 g.
Cross-lapper intended to deliver at its output a web of fibres from a fleece of fibres delivered at its input, the cross-lapper overlaying sections of the fleece to form the web at its output and comprising a front belt, a rear belt and means of reversal to reverse the fleece of fibres to change it from a state in which it is supported by the front belt to a state in which it is supported by the rear belt, characterised in that placed on top of the reversal region where the fleece is reversed, is a rotating part, for example a roller or cylinder, being driven in rotation and placed such that a local overpressure is created by the Magnus effect in the region of reversal, the rotating part, in particular the roller driven in rotation, being driven by a motor.
A preparation method of a porous super absorbent polymer, comprising the steps of: preparing a monomer neutralized solution by adding an internal cross-linking agent, an initiator, an inorganic filler, and a nonionic surfactant to a neutralized solution obtained by neutralizing at least 80 mol% of a water soluble ethylene-based unsaturated monomer containing acidic groups; high-shear mixing the monomer neutralized solution; preparing a hydrogel polymer from the high-shear mixed monomer neutralized solution by thermal polymerization or photopolymerization; and preparing a base resin powder by drying, pulverizing, and classifying the hydrogel polymer, wherein the internal cross-linking agent comprises at least one selected from the group consisting of polyethylene glycol diacrylate (PEGDA), glycerine diacrylate, glycerine triacrylate, unmodified or ethoxylated trimethylol triacrylate (TMPTA), hexanediol diacrylate, and triethylene glycol diacrylate, and wherein the inorganic filler is a silica nanoparticle or an alumina nanoparticle surface-modified with a cross-linkable or hydrophilic functional group containing at least one functional group selected from the group consisting of a (meth)acrylate-based functional group, an allyl group, a vinyl group, an epoxy group, a hydroxyl group, an isocyanate group and an amine group. preparing a monomer neutralized solution by adding an internal cross-linking agent, an initiator, an inorganic filler, and a nonionic surfactant to a neutralized solution obtained by neutralizing at least 80 mol% of a water soluble ethylene-based unsaturated monomer containing acidic groups; high-shear mixing the monomer neutralized solution; preparing a hydrogel polymer from the high-shear mixed monomer neutralized solution by thermal polymerization or photopolymerization; and preparing a base resin powder by drying, pulverizing, and classifying the hydrogel polymer, wherein the internal cross-linking agent comprises at least one selected from the group consisting of polyethylene glycol diacrylate (PEGDA), glycerine diacrylate, glycerine triacrylate, unmodified or ethoxylated trimethylol triacrylate (TMPTA), hexanediol diacrylate, and triethylene glycol diacrylate, and wherein the inorganic filler is a silica nanoparticle or an alumina nanoparticle surface-modified with a cross-linkable or hydrophilic functional group containing at least one functional group selected from the group consisting of a (meth)acrylate-based functional group, an allyl group, a vinyl group, an epoxy group, a hydroxyl group, an isocyanate group and an amine group.
Electric switchgear arrangement, consisting of an electric switchgear and a design module covering at least two mounting spaces of such electric switchgear, wherein the electric switchgear is provided with an actuating element covering at least two mounting spaces of such electric switchgear, characterized by the fact that the design module consists of a design frame and of a function plate to be inserted detachably into the design frame.
A composition comprising solid particles of a cyclopropene complex, containing a cyclopropene molecule or a portion of a cyclopropene molecule encapsulated in a molecule of a molecular encapsulating agent, wherein said molecular encapsulating agent is alpha-cyclodextrin, beta-cyclodextrin, gamma-cyclodextrin, or a mixture thereof; and wherein said cyclopropene molecule is a compound with the formula wherein R 1 is methyl and each of R 2, R 3 and R 4 is hydrogen; characterised in that said composition additionally comprises an oil medium, that said solid particles are suspended in said oil medium, and that said solid particles have median size, as measured by the largest dimension, of 50 micrometer or less.
A cosmetic container provided with a rubber discharge pad, which includes an outer container provided with a container body containing groove, and an outer container lid hinge-coupled to the outer container to be opened or closed, the cosmetic container comprising: a container body contained in the outer container and provided with an inner wall; a frame coupled to an upper end of the container body; a rubber discharge pad coupled to an upper end of frame and provided with an outlet; and a tension cap coupled to the rubber discharge pad and the frame, wherein the rubber discharge pad is provided on an end thereof with an inserting part, the inserting part is fitted with a coupling protrusion of the frame to fixedly couple the frame to the inner wall of the container body, the tension cap is provided with a tension protrusion and coupled to the container body, and the tension protrusion presses a rim of the rubber discharge pad to expand the rubber discharge pad. a container body contained in the outer container and provided with an inner wall; a frame coupled to an upper end of the container body; a rubber discharge pad coupled to an upper end of frame and provided with an outlet; and a tension cap coupled to the rubber discharge pad and the frame, wherein the rubber discharge pad is provided on an end thereof with an inserting part, the inserting part is fitted with a coupling protrusion of the frame to fixedly couple the frame to the inner wall of the container body, the tension cap is provided with a tension protrusion and coupled to the container body, and the tension protrusion presses a rim of the rubber discharge pad to expand the rubber discharge pad.
A passive infrared security sensor comprising: a focal plane array including a plurality of imaging pixels, whereby each of said imaging pixels includes a mosaic of sub-pixels that are electrically interconnected within the focal plane to form a resistor network, the mosaic of sub-pixels being arranged to form a mosaic pixel focal plane array (MP-FPA) and each said sub-pixel being a resistance microbolometer infrared detector; a signal readout means; an infra-red transmitting lens; a signal processing means; and a display means. a focal plane array including a plurality of imaging pixels, whereby each of said imaging pixels includes a mosaic of sub-pixels that are electrically interconnected within the focal plane to form a resistor network, the mosaic of sub-pixels being arranged to form a mosaic pixel focal plane array (MP-FPA) and each said sub-pixel being a resistance microbolometer infrared detector; a signal readout means; an infra-red transmitting lens; a signal processing means; and a display means.
A recharging system for an aerosol generating device comprising: an aerosol generating device configured to generate aerosol by heating an aerosol generating material; and a power supply device having an inner space into which the aerosol generating device is insertable wherein the power supply device comprises: a first case; a second case coupled to the first case to form the inner space; a first plate that is disposed in the first case; and a second plate that is disposed in the second case, wherein the first plate and the second plate are formed of a thermally conductive material, and wherein at least one end of the first plate is exposed out of the first case and at least one end of the second plate is exposed out of the second case, such that the exposed end of the first plate and the exposed end of the second plate are in contact with each other based on the first case and the second case being coupled to each other an aerosol generating device configured to generate aerosol by heating an aerosol generating material; and a power supply device having an inner space into which the aerosol generating device is insertable wherein the power supply device comprises: a first case; a second case coupled to the first case to form the inner space; a first plate that is disposed in the first case; and a second plate that is disposed in the second case, a first case; a second case coupled to the first case to form the inner space; a first plate that is disposed in the first case; and a second plate that is disposed in the second case, wherein the first plate and the second plate are formed of a thermally conductive material, and wherein at least one end of the first plate is exposed out of the first case and at least one end of the second plate is exposed out of the second case, such that the exposed end of the first plate and the exposed end of the second plate are in contact with each other based on the first case and the second case being coupled to each other
A pneumococcal vaccine comprising saccharide from serotypes 4, 6B, 9V, 14, 18C, 19F and 23F individually conjugated to CRM197 and at least one TLR-9 agonist as adjuvant wherein said at least one TLR-9 agonist is a CpG Oligonucleotide having the nucleic acid sequence selected from the group consisting of: 5' TCGTCGTTTTTCGGTGCTTTT 3' (SEQ ID NO: 3), 5' TCGTCGTTTTTCGGTCGTTTT 3' (SEQ ID NO: 4), 5' TCGTCGTTTTGTCGTTTTGTCGTT 3' (SEQ ID NO: 5), 5' TCGTCGTTTCGTCGTTTTGTCGTT 3' (SEQ ID NO: 6) and 5' TCGTCGTTTTGTCGTTTTTTTCGA 3' (SEQ ID NO: 7) for use in the prevention or treatment of diseases caused by S. pneumoniae infection in an immunocompromised subject wherein said immunocompromised subject suffers from HIV-infection or acquired immunodeficiency syndrome (AIDS) and is under highly active antiretroviral therapy (HAART).
Pharmaceutical composition comprising at least one agonist of the receptor of the Toll 4 type, for use in the prophylactic treatment of septic complications of post-traumatic systemic immunodepression in a hospitalised patient suffering from one or more severe traumas, said agonist being chosen from monophosphoryl lipid A (MPLA) and 3-0-deacylated monophosphoryl lipid A (3D-MPLA).
A method for accessing and processing data by an accelerator apparatus, comprising: retrieving at least a part of input data to be processed by the accelerator apparatus; segmenting the input data into a plurality of adjacent input tiles, the input tiles having a pre-determined size; storing at least one of the plurality of adjacent input tiles in a data buffer of the accelerator apparatus; accessing data elements of the at least one of the plurality of adjacent input tiles stored in the data buffer by positioning an input window over the data elements stored in the data buffer, to generate a plurality of input areas, wherein the input window is adjustable according to a set of parameters, and wherein accessing the data elements via the input window is hard-wired in a circuitry implementing the data buffer; and sequentially processing at least one of the plurality of input areas to at least partially process the at least one of the plurality of adjacent input tiles by the accelerator apparatus. retrieving at least a part of input data to be processed by the accelerator apparatus; segmenting the input data into a plurality of adjacent input tiles, the input tiles having a pre-determined size; storing at least one of the plurality of adjacent input tiles in a data buffer of the accelerator apparatus; accessing data elements of the at least one of the plurality of adjacent input tiles stored in the data buffer by positioning an input window over the data elements stored in the data buffer, to generate a plurality of input areas, wherein the input window is adjustable according to a set of parameters, and wherein accessing the data elements via the input window is hard-wired in a circuitry implementing the data buffer; and sequentially processing at least one of the plurality of input areas to at least partially process the at least one of the plurality of adjacent input tiles by the accelerator apparatus.
A fluctuation absorbing apparatus, comprising: a first plate (11; 31; 41; 51; 61; 71) fixed to a flywheel; a second plate (13; 32; 42; 52; 62;) disposed at a distance from the first plate; a third plate slidably sandwiched between the first plate and the second plate; and a resilient section (12; 43; 51a; 63; 72a; 81; 91) that is supported by, fixed to or integrated with the first plate or the second plate and biases the second plate toward the first plate, wherein one plate of the first and second plates has a plurality of holes or recesses; the resilient section is an annular disc spring supported by said one plate; the other plate of the first and second plates has a plurality of support parts (13a; 31a) that receive a pressing force of the annular disc spring through the corresponding holes or recesses, and the support parts each have a first bending section (13c; 31c; 51c; 72c) bent toward said one plate on its proximal end side and a second bending section (13b; 31b; 51b; 72b) bent toward a radially inner circumference side on its distal side, and receive a pressing force of the annular disc spring in a region more distal than the second bending section, the fluctuation absorbing apparatus being characterized in that one or both of the first bending section and the second bending section of each of the support parts has a guide recess or a guide hole that guides the bending to form the bending section. a first plate (11; 31; 41; 51; 61; 71) fixed to a flywheel; a second plate (13; 32; 42; 52; 62;) disposed at a distance from the first plate; a third plate slidably sandwiched between the first plate and the second plate; and a resilient section (12; 43; 51a; 63; 72a; 81; 91) that is supported by, fixed to or integrated with the first plate or the second plate and biases the second plate toward the first plate, wherein one plate of the first and second plates has a plurality of holes or recesses; the resilient section is an annular disc spring supported by said one plate; the other plate of the first and second plates has a plurality of support parts (13a; 31a) that receive a pressing force of the annular disc spring through the corresponding holes or recesses, and the support parts each have a first bending section (13c; 31c; 51c; 72c) bent toward said one plate on its proximal end side and a second bending section (13b; 31b; 51b; 72b) bent toward a radially inner circumference side on its distal side, and receive a pressing force of the annular disc spring in a region more distal than the second bending section, the fluctuation absorbing apparatus being characterized in that one or both of the first bending section and the second bending section of each of the support parts has a guide recess or a guide hole that guides the bending to form the bending section.
An automatic transmission comprising a friction engaging element, the friction engaging element including: a plurality of friction plates disposed inside a transmission case; a piston configured to cause the plurality of friction plates to be engaged with each other; a spring configured to bias the piston; and a hydraulic chamber to which hydraulic fluid is supplied, the hydraulic fluid biasing the piston, wherein the hydraulic chamber is disposed at a different radial position from the spring but axially overlaps with the spring, and/or the spring is disposed between the hydraulic chamber and the transmission case; characterized in that the hydraulic chamber includes a hydraulic chamber for engagement to which hydraulic fluid to bias the piston in an engaging direction is supplied, and a hydraulic chamber for release disposed at an opposite side of the piston from the hydraulic chamber for engagement, the hydraulic chamber for release being configured to be supplied with hydraulic fluid to bias the piston in a releasing direction opposite from the engaging direction. a plurality of friction plates disposed inside a transmission case; a piston configured to cause the plurality of friction plates to be engaged with each other; a spring configured to bias the piston; and a hydraulic chamber to which hydraulic fluid is supplied, the hydraulic fluid biasing the piston, wherein the hydraulic chamber is disposed at a different radial position from the spring but axially overlaps with the spring, and/or the spring is disposed between the hydraulic chamber and the transmission case; characterized in that the hydraulic chamber includes a hydraulic chamber for engagement to which hydraulic fluid to bias the piston in an engaging direction is supplied, and a hydraulic chamber for release disposed at an opposite side of the piston from the hydraulic chamber for engagement, the hydraulic chamber for release being configured to be supplied with hydraulic fluid to bias the piston in a releasing direction opposite from the engaging direction.
A pharmaceutical composition for direct systemic introduction comprising: about 10-15 mass% bovine gelatin, about 10-15 mass% mannitol, about 0.001-0.7 mass% of a surfactant, about 0.001-0.4 mass% of a flavorant; and about 65-85 mass% of a proton pump inhibitor, wherein the proton pump inhibitor is omeprazole or esomeprazole. about 10-15 mass% bovine gelatin, about 10-15 mass% mannitol, about 0.001-0.7 mass% of a surfactant, about 0.001-0.4 mass% of a flavorant; and about 65-85 mass% of a proton pump inhibitor,